COVID-19 vaccine trials: Duty of care and standard of prevention considerations

Vaccine. 2020 Nov 10;38(48):7578-7580. doi: 10.1016/j.vaccine.2020.10.012. Epub 2020 Oct 9.

Author

Jerome Amir Singh¹

Affiliation

¹ CAPRISA, University of KwaZulu-Natal, Durban, South Africa; Department of Clinical Public Health, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada; Howard College School of Law, University of KwaZulu-Natal, King George V Ave, Durban 4001, South Africa. Electronic address: singhj9@ukzn.ac.za.

No abstract available

MeSH terms

Betacoronavirus / immunology
Betacoronavirus / pathogenicity
COVID-19
COVID-19 Vaccines
Clinical Trials as Topic
Coronavirus Infections / epidemiology*
Coronavirus Infections / immunology
Coronavirus Infections / prevention & control*
Coronavirus Infections / virology
Drug Approval / legislation & jurisprudence
Humans
International Cooperation
Pandemics / prevention & control*
Patient Safety
Personal Protective Equipment / ethics
Personal Protective Equipment / supply & distribution*
Pneumonia, Viral / epidemiology*
Pneumonia, Viral / immunology
Pneumonia, Viral / prevention & control*
Pneumonia, Viral / virology
Practice Guidelines as Topic
Risk Assessment*
SARS-CoV-2
Viral Vaccines / administration & dosage*
Viral Vaccines / biosynthesis

Substances

COVID-19 Vaccines
Viral Vaccines